Quick Summary:
The dynamic, globally significant Glufosinate market is undergoing substantial growth and transformation. As a leader, staying ahead of this changing landscape requires deep insight and a robust understanding of market movements. Our detailed Global Glufosinate Market report offers an invaluable resource in navigating these complexities and harnessing the market's full potential.
This comprehensive report reveals the market's projected value of US$4.5 billion by 2030, significant growth drivers, and influential factors to keep on your radar. The data includes an in-depth analysis of the high-potential Genetically Modified segment, currently set for an 8.4% CAGR and bound to reach US$3.4 billion. With robust coverage of key markets including the United States, China, Europe, Canada, and Japan, this report is your ultimate guide to positioning your business for maximum advantage in the vibrant global Glufosinate market. Capitalize on this opportunity and secure your copy today.
Global Glufosinate Market to Reach $4.5 Billion by 2030
The global market for Glufosinate estimated at US$2.4 Billion in the year 2022, is projected to reach a revised size of US$4.5 Billion by 2030, growing at a CAGR of 8% over the analysis period 2022-2030. Genetically Modified, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Conventional segment is readjusted to a revised 6.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $646.5 Million, While China is Forecast to Grow at 11.8% CAGR
The Glufosinate market in the U.S. is estimated at US$646.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 11.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 7.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.Select Competitors (Total 44 Featured) -
- Bayer AG
- Bayer CropScience AG
- Dow, Inc.
- DuPont de Nemours, Inc.
- Jiangsu Huangma Agrochemicals Co., Ltd.
- Jiangsu Sevencontinent Green Chemical Co., Ltd.
- LIER Chemical Co., Ltd.
- Nufarm Limited
- Syngenta AG
- UPL Ltd.
- Veyong (Hebei Veyong Bio-Chemical Co. Ltd)
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Glufosinate?
What is the growth rate of the Global Market for Glufosinate?
What is the forecasted size of the Global Market for Glufosinate?
Who are the key companies in the Global Market for Glufosinate?
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | November 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 2.4 Billion |
| Forecasted Market Value ( USD | $ 4.5 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bayer AG
- Bayer CropScience AG
- Dow, Inc.
- DuPont de Nemours, Inc.
- Jiangsu Huangma Agrochemicals Co., Ltd.
- Jiangsu Sevencontinent Green Chemical Co., Ltd.
- LIER Chemical Co., Ltd.
- Nufarm Limited
- Syngenta AG
- UPL Ltd.
- Veyong (Hebei Veyong Bio-Chemical Co. Ltd)
